Photocure ASA: Exclusive Nordic distribution agreement for innovative drug delivery system for bladder cancer patients
Oslo, Norway, August 27, 2018: Photocure ASA, The Bladder Cancer Company, announces today that an exclusive distribution agreement for the Nordic area for an innovative and patented medical device has been signed with Combat Medical (www.combat-medical.com). The device is designed for the delivery of Hyperthermic Intra-Vesical Chemotherapy (HIVEC[®]) for non-muscle invasive bladder cancer and has a strong strategic and synergistic fit with current business. "The distribution agreement with Combat Medical is a milestone for Photocure as it represents the first step in expanding our